However, pharmacological agents like chrysin nanoparticles (CCNPs), which restore CII activity and SIRT3 expression, have demonstrated significant potential in reactivating ETC function, thereby inducing apoptosis and reducing the viability of pancreatic cancer cells. Here, SIRT3 is linked to familial pancreatic carcinoma.